[HTML][HTML] Prostate cancer: the role of inflammation and chemokines

A Rani, P Dasgupta, JJ Murphy - The American journal of pathology, 2019 - Elsevier
Prostate cancer (PC) is a leading cause of death in men. Inflammation is one of the initiating
processes whereby cells are trafficked into the tumor microenvironment by specific cytokines …

The role of GATA2 in lethal prostate cancer aggressiveness

V Rodriguez-Bravo, M Carceles-Cordon… - Nature Reviews …, 2017 - nature.com
Advanced prostate cancer is a classic example of the intractability and consequent lethality
that characterizes metastatic carcinomas. Novel treatments have improved the survival of …

Cell plasticity and prostate cancer: The role of epithelial–mesenchymal transition in tumor progression, invasion, metastasis and cancer therapy resistance

S Papanikolaou, A Vourda, S Syggelos, K Gyftopoulos - Cancers, 2021 - mdpi.com
Simple Summary Although epithelial-to-mesenchymal transition (EMT) is a well-known
cellular process involved during normal embryogenesis and wound healing, it also has a …

CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+ Pools

JP Chmielewski, SC Bowlby, FB Wheeler, L Shi… - Molecular Cancer …, 2018 - AACR
Tumor cells require increased rates of cell metabolism to generate the macromolecules
necessary to sustain proliferation. They rely heavily on NAD+ as a cofactor for multiple …

Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells

L Zhang, J Sha, G Yang, X Huang, J Bo, Y Huang - Cell Cycle, 2017 - Taylor & Francis
Notch signaling has been reported to play an essential role in tumorigenesis. Several
studies have suggested that Notch receptors could be oncoproteins or tumor suppressors in …

Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model

OJ Kwon, L Zhang, J Wang, Q Su… - The Journal of …, 2016 - Am Soc Clin Investig
Although Notch signaling is deregulated in prostate cancer, the role of this pathway in
disease development and progression is not fully understood. Here, we analyzed 2 human …

Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways

K Feng, C Liu, W Wang, P Kong… - … Journal of Oncology, 2023 - spandidos-publications.com
Despite achieving optimal initial responses to androgen deprivation therapy, most patients
with prostate cancer eventually progress to a poor prognosis state known as castration …

Deregulated miRNAs in enzalutamide resistant prostate cancer: A comprehensive review of key molecular alterations and clinical outcomes

I Tavares, M Morais, F Dias, R Medeiros… - Biochimica et Biophysica …, 2023 - Elsevier
Prostate cancer (PC) is the second most frequently diagnosed cancer and the fifth leading
cause of cancer-related deaths in male population worldwide. Since the growth and …

[HTML][HTML] The role of cyclins in the development and progression of prostate cancer

J Dulińska-Litewka, D Felkle, K Dykas… - Biomedicine & …, 2022 - Elsevier
The role of cyclins in hormone-dependent neoplasms is crucial in the development of the
disease that is resistant to first-line therapy, as the example of breast cancer shows …

Inflammation in urological malignancies: the silent killer

M Catalano, G Roviello, R Santi, D Villari… - International Journal of …, 2023 - mdpi.com
Several studies have investigated the role of inflammation in promoting tumorigenesis and
cancer progression. Neoplastic as well as surrounding stromal and inflammatory cells …